Phico Therapeutics Limited
04062313
Details
Compliance
Last accounts
31/08/2022
total exemption full
Next accounts due
31/05/2024
Confirmation statement
Last: 30/08/2023
Due 13/09/2024
Industry
Officers
director · Since 19/10/2018
HOSPITAL CONSULTANT
BRITISH · ENGLAND · Age 64
director · Since 01/12/2018
BIOTECHNOLOGY EXECUTIVE
BRITISH · ENGLAND · Age 57
Also on 1 other board
Persons with Significant Control
Bgf Gp Limited
13-15, York Buildings, London, WC2N 6JU
Reg: 10657217 · Companies House · Private Limited Company
Notified 13/08/2020
Charges0 outstanding
BGF NOMINEES LIMITED
Insolvency History1 case
Allister Manson (practitioner) · Steven John Parker (practitioner) · Charles Hamilton Turner (practitioner)
CompanyRankvs 15+ SIC 21100 peers32
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Insolvency history: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/08/2022
Net Worth
£6k
Balance sheet strength
Cash
£78k
Cash in the bank
Net Current Assets
£440k
Working capital
Current Assets
£1.3M
Current Liabilities
£904k
Fixed Assets
£126k
Debtors
£1.3M
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2022 | 1.49 | +£0 |
| 2021 | 6.97 | — |
Derived from filed accounts. Not audited figures.